Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-06

FDA Approved: DISULFIRAM — Supplemental Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Disulfiram (DISULFIRAM) submitted by Sigmapharm Laboratories, LLC. The notice does not specify the exact nature of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)

Snippet

SUPPL AP for DISULFIRAM (DISULFIRAM)